Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies David Hung files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Gary Hattersley - $3.88M in NUVB purchases and sales in the last 12 months
- Dongfang Liu - $1.87M in NUVB purchases and sales in the last 12 months
- Kerry Wentworth - $1.47M in NUVB purchases and sales in the last 12 months
- David C. Hanley - $1.43M in NUVB purchases and sales in the last 12 months
- William F. Doyle - $933K in NVCR purchases and sales in the last 12 months
- Frank X. Leonard - $920K in NVCR purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is David Hung?
David Hung is a corporate insider of NovoCure Ltd (NVCR). InsiderAlpha holds 3 primary Form 4 filings for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
When did David Hung last file a Form 4?
The most recent primary Form 4 on record is dated 5 June 2026, one of 3 filings going back to 2026.
Has David Hung been buying or selling stock?
Recorded transactions: 0 open-market purchases and 1 open-market sale ($46K) across all tracked filings.
